Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Raises $6.2M in Private Financings

NEW YORK (GenomeWeb News) – WaferGen Biosystems has raised gross proceeds of approximately $6.2 million through a series of private placements between June 16 and Aug. 31, the firm said today.

The publicly traded maker of gene expression and genotyping systems said that it issued roughly 5 million shares of common stock at a price of $1.25 per share, along with warrants to purchase 1,502,700 shares of common stock, at an exercise price of $2 per share. The warrants have a five-year term, the firm said.

WaferGen said that it would use proceeds from the offerings to fund advancement and commercialization of its SmartChip Real-Time PCR System.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.